Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Prostatic Neoplasms: HELP
Christophe Massard
Based on 53 articles published since 2008
||||
Expertise Level
The expertise of Christophe Massard ranks in the
  • Top 0.18%
  • ... of 138,005 published authors worldwide on Prostatic Neoplasms
  • ... from 2008 through 2019
  • ... based on contributions to 53 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
Expert badge
similar to this:
 
Aliases Massard, C   ·   Massard, Christophe
Work Locations
Details
Most likely:    Institut Gustave Roussy      
2018
  • Institut Médical d'Analyse Génomique, Clinique BeauSoleil, Montpellier, France. Electronic address: · Service de Pathologie, CHU Henri Mondor, Créteil, France. · UMR-S INSERM 1039, Institut de Biologie et de Pathologie, CHU Grenoble, Grenoble, France. · IR4M-UMR8081, Université Paris-Sud, Paris, France. · Département Oncologie Médicale, Institut Curie, Paris, France. · Hôpital Saint-Louis, Paris, France. · CHU Henri Mondor, Créteil, France. · Médecine Nucléaire, CHU Bordeaux, Bordeaux, France. · Institut Gustave Roussy, Villejuif, France. · Département d'Imagerie Médicale, CHU Lapeyronie, Montpellier, France. · CHU Montpellier, Montpellier, France. · Service de Biologie Cellulaire, Hôpital Saint-Louis, AP-HP, Paris, France. · Department of Urinary and Vascular Radiology, Hospices Civils de Lyon, Hôpital Edouard Herriot-Université Lyon 1, Lyon, France. · Intergroupe Coopérateur Francophone de Recherche en Onco-urologie, Paris, France. · Institut Mutualiste Montsouris, Paris-Université Paris Descartes, Paris, France. · CHU Grenoble, France. · Service d'Urologie, Clinique BeauSoleil, Montpellier, France. · Pubmed 28753865
  • Carolina Urologic Research Center, Myrtle Beach, SC, USA. Electronic address: · Tampere University Hospital, Department of Urology, Tampere, Finland. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Comprehensive Cancer Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland. · Orion Corporation, Orion Pharma, Espoo, Finland. · Pubmed 28753851
2017
  • University of Paris Sud, Gustave-Roussy Cancer Campus, Drug Development Department and Department of Medical Oncology, 114, rue Édouard-Vaillant, 94805 Villejuif cedex, France. · University of Paris Sud, Gustave-Roussy Cancer Campus, Drug Development Department and Department of Medical Oncology, 114, rue Édouard-Vaillant, 94805 Villejuif cedex, France. Electronic address: · Pubmed 28237355
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Comprehensive Cancer Center, Helsinki University Hospital, University of Helsinki, Helsinki, Finland. · Kuopio University Hospital, Kuopio, Finland. · Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK. · Tampere University Hospital, Tampere, Finland. · Orion Corporation, Orion Pharma, Espoo, Finland. · Pubmed 28753849
  • Drug Development Department, Gustave Roussy, University of Paris Sud, Villejuif, France; Department of Cancer Medicine, Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · BC Cancer Agency, Vancouver, Canada. · University Hospital 12 de Octubre, CIBER-ONC, Madrid, Spain. · Institute of Cancer Research, London, UK. · Institut Paoli-Calmettes, Marseille, France. · St. Augustinus Hospital, Antwerp, Belgium. · Institut Roi Albert II, Service d'Oncologie Médicale, Cliniques universitaires Saint-Luc and Institut de Recherche Clinique et Expérimentale, Université catholique de Louvain, Brussels, Belgium. · Cedars-Sinai Medical Center, Los Angeles, CA, USA. · Medical Oncology Department, Hospital Clínic, IDIBAPS, Barcelona, Spain. · Novartis Pharma S.A.S, Rueil-Malmaison, France. · Novartis Pharma AG, Basel, Switzerland. · Novartis Healthcare Pvt. Ltd., Hyderabad, India. · Department of Cancer Medicine, Gustave Roussy, University of Paris Sud, France. · Pubmed 28282611
  • Department of Drug Development, Gustave Roussy Cancer Campus, University of Paris Sud, Villejuif, France. · Department of Medical Oncology, Gustave Roussy Cancer Campus, University of Paris Sud, Villejuif, France. · The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, USA. · Comprehensive Cancer Center Yale School of Medicine, New Haven. · Sanofi Genzyme, Cambridge, USA. · Pubmed 28039155
  • Institut Gustave Roussy, University of Paris-Sud, Department of Cancer Medicine, 114 Rue Edouard Vaillant, 94800 Villejuif, France. · Institut Paoli-Calmettes, Department of Medical Oncology, 13009 Marseille, France. · Pubmed 28428880
  • Institut Montsouris, université Paris Descartes, 42, boulevard Jourdan, 75014 Paris, France. Electronic address: · Hôpital Pitié Salpêtrière, Assistance publique-Hôpitaux de Paris, faculté de médecine Pierre-et-Marie-Curie, université Paris 6, 47-83, boulevard de l'Hôpital, 75013 Paris, France. · Hôpital St-Louis, université Paris Diderot, 1, avenue Claude-Vellefaux, 75010 Paris, France. · Institut Gustave-Roussy, 114, rue Édouard-Vaillant, 94800 Villejuif, France. · Institut Bergonié, 229, cours de l'Argonne, 33000 Bordeaux, France. · Pubmed 28392429
  • CHRU de Lille, medical oncology department, rue Michel-Polonovski, 59037 Lille cedex, France; Institut de biologie de Lille, CNRS-UMR8161, 1, rue du Professeur-Calmette, 59021 Lille cedex, France. Electronic address: · Centre Oscar-Lambret, department of radiotherapy, 3, rue F.-Combemale, 59020 Lille, France. · Gustave-Roussy hospital, department of therapeutic innovation and early trials, 114, rue Edouard-Vaillant, 94800 Villejuif, France. · Clinique Sainte-Marguerite, medical oncology department, oncovar, avenue Alexis-Godillot, 83400 Hyères, France. · AP-HP, Saint-Louis hospital, medical oncology, 75010 Paris, France. · Centre Oscar-Lambret, medical oncology department, 3, rue F.-Combemale, 59020 Lille, France; SIRIC ONCOLille Consortium, Clinical Research and Methodology Platform, 59000 Lille, France. · Pubmed 28390646
2016
  • Hôpitaux de Chartres Oncologie-Hématologie, 6, rue Claude-Bernard, 28630 Chartes Le Coudray, France. Electronic address: · CHU de Clermont-Ferrand, service de thérapie cellulaire et d'hématologie clinique adulte, 1, place Lucie-Aubrac, 63003 Clermont-Ferrand cedex 1, France. · Institut Gustave-Roussy, département de médecine, 114, rue Édouard-Vaillant, 94800 Villejuif, France. · Centre Antoine-Lacassagne, département de radiothérapie, 33, avenue Valombrose, 06189 Nice, France. · Pubmed 27770995
  • Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. · Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. Electronic address: · Pubmed 27151554
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Comprehensive Cancer Center, Helsinki University Central Hospital and University of Helsinki, Helsinki, Finland. · Stradins Clinical University Hospital, Riga, Latvia. · Riga East University Hospital, Riga, Latvia. · Tampere University Hospital and School of Medicine, University of Tampere, Tampere, Finland. · Orion Corporation, Orion Pharma, Espoo, Finland. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Pubmed 26463318
  • Gustave Roussy, Université Paris-Saclay, Department of Medicine, F-94805, Villejuif, France. · INSERM, U981 "Identification of Molecular Predictors and New Targets for Cancer Treatment", F-94805, Villejuif, France. · Gustave Roussy, Université Paris-Saclay, "Circulating Tumor Cells" Translational Platform, AMMICA CNRS UMS3655 - INSERM US23, F-94805, Villejuif, France. · Hôpital d'Instruction des Armées du Val de Grâce, Department of Oncology, F-75005, Paris, France. · Gustave Roussy, Université Paris-Saclay, Department of Biopathology, F-94805, Villejuif, France. · Gustave Roussy, Université Paris-Saclay, Department of Biostatistics and Epidemiology, F-94805, Villejuif, France. · Gustave Roussy, Université Paris-Saclay, "Histo Cytopathology" Translational Platform, AMMICA CNRS UMS3655 - INSERM US23, F-94805, Villejuif, France. · Pubmed 27391263
  • INSERM U981, University of Paris-Sud XI, Translational Research Laboratory, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Medical Oncology, Bergonie Cancer Institute, Bordeaux, France. · INSERM U981, University of Paris-Sud XI, Translational Research Laboratory, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. · INSERM U981, University of Paris-Sud XI, Translational Research Laboratory, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Biopathology, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. · INSERM U981, University of Paris-Sud XI, Translational Research Laboratory, Gustave Roussy Cancer Campus, Villejuif, France. · Pubmed 26923772
  • Department of Medical Oncology, Institut Bergonié, Bordeaux. · Department of Medical Oncology, Clinique Francheville, Périgueux. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif. · Department of Radiotherapy, Institut Bergonié, Bordeaux, France. · Department of Medical Oncology, Institut Bergonié, Bordeaux · Pubmed 26445811
2015
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Pubmed 25922192
  • Institut Curie, département d'oncologie médicale, 26, rue d'Ulm, 75005 Paris, France. Electronic address: · Institut Gustave-Roussy, département d'oncologie médicale, 94076 Villejuif, France. · Pubmed 26028494
  • Gustave-Roussy, département innovation thérapeutique et essais précoces, 114, rue Édouard-Vaillant, 94805 Villejuif, France. · Gustave-Roussy, département innovation thérapeutique et essais précoces, 114, rue Édouard-Vaillant, 94805 Villejuif, France. Electronic address: · Pubmed 26022286
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Nyack Hospital, Nyack, NY, USA. · Cancer Research UK Experimental Cancer Medicine Centres, Leeds and Sheffield, UK. · Department of Radiotherapy, Greater Poland Cancer Center and Department of Electroradiology, Medical University, Poznań, Poland. · Carolina Urologic Research Center, Myrtle Beach, SC, USA. · European Georges Pompidou Hospital, Paris, France. · The Urology Center of Colorado, Denver, CO, USA. · Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA. · Universitario Pedro Ernesto, Rio De Janeiro, Brazil. · Amgen Inc., Thousand Oaks, CA, USA. · Pubmed 25449207
  • Department of Ambulatory Care, Gustave-Roussy Cancer Campus, University of Paris Sud, Villejuif, France. Electronic address: · Department of Biostatistics and Epidemiology, Gustave-Roussy Cancer Campus, University of Paris Sud, Villejuif, France. · Department of Cancer Medicine, Gustave-Roussy Cancer Campus, Villejuif, University of Paris Sud, France. · Department of Ambulatory Care, Gustave-Roussy Cancer Campus, University of Paris Sud, Villejuif, France. · Pubmed 26278649
  • Department of Cancer Medicine, Gustave Roussy Institute, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. Electronic address: · Institut Jean Godinot, Reims, France. · Department of Cancer Medicine, Gustave Roussy Institute, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. · Pubmed 26208462
  • Department of Cancer Medicine, Gustave Roussy Institute, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. · Department of Urology, University Hospital of Pointe-à-Pitre, France. · Department of Urology, Kremlin-Bicêtre Hospital, University of Paris-Sud, Kremlin-Bicêtre, France. · Department of Urology, Saint-Joseph Hospital, Paris, France. · Department of Radiotherapy, Gustave Roussy Institute, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. · Department of Forestry and Management of the Environment and Natural Resources, School of Agricultural Sciences and Forestry, Democritus University, Alexandroupoli, Greece. · Department of Cancer Medicine, Gustave Roussy Institute, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. Electronic address: · Pubmed 25746940
  • Unit of Urology/Division of Oncology; URI; IRCCS Ospedale San Raffaele, Milan, Italy. · Department of Urology, Saint-Louis Hospital, Paris, France. · Department of Urology, Regio Clinic Wedel, Wedel, Germany; Martini-Clinic, Prostate Cancer Center Hamburg-Eppendorf, Germany. · Department of Radiology, Ghent University Hospital, Ghent, Belgium. · Department of Radiology, Radboud University, Nijmegen Medical Centre, Nijmegen, The Netherlands. · Department of Radiation Oncology, Charité Universitätsmedizin Berlin, Berlin, Germany. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Radiation Oncology and Experimental Cancer Research, Ghent University Hospital, Ghent, Belgium. · Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK. · Centre of Urological Surgery, Dialysis and Renal Transplantation, Fundeni Clinical Institute, Bucharest, Romania. · Department of Urology, University Medical Centre Utrecht, Utrecht, The Netherlands. · Department of Experimental and Clinical Medical Sciences, University of Udine, Udine, Italy. · Unit of Urology/Division of Oncology; URI; IRCCS Ospedale San Raffaele, Milan, Italy. Electronic address: · Pubmed 25620154
  • Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia, Canada. · Department of Medical Oncology, Val de Grâce Hospital, Paris, France. · Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, and INSERM U981, Villejuif, France. · Department of Medical Oncology, Institut Curie, Paris, France. · Department of Medical Oncology, CHU de Bordeaux, Bordeaux, France. · Pitié-Salpetrière Hospital, Paris, France. · Institut de Cancérologie de la Loire, Saint-Etienne, France. · Biostatistics and Epidemiology unit, Institut Gustave Roussy, Cancer Campus, Grand Paris, Villejuif, France. · Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, and INSERM U981, Villejuif, France. Electronic address: · Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, and INSERM U981, Villejuif, France. Electronic address: · Pubmed 24837187
2014
  • Department of Cancer Medicine, Institut Gustave Roussy and University of Paris Sud, Villejuif, France. · Department of Cancer Medicine, Institut Gustave Roussy and University of Paris Sud, Villejuif, France; Drug Development Department, SITEP, Institut Gustave Roussy, Villejuif, France. Electronic address: · Pubmed 24735730
  • Institut Gustave-Roussy, DITEP, Département d'innovations thérapeutiques et essais précoces, 114, rue Édouard-Vaillant, 94805 Villejuif cedex, France. · Institut Gustave-Roussy, Département de médecine oncologique, 114, rue Édouard-Vaillant, 94805 Villejuif cedex, France. · Service d'oncologie et hématologie, 4, rue Louis-Pasteur, 28630 Chartres Le Coudray, France. · Pubmed 24793632
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Cancer Center, Helsinki University Central Hospital, Helsinki, Finland. · Velindre Cancer Centre, Cardiff, UK. · Kuopio University Hospital, Kuopio, Finland. · Queen Elizabeth Hospital, Birmingham, UK. · Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, USA. · Churchill Hospital, Oxford, UK. · Tampere University Hospital, Tampere, Finland. · Christie Hospital NHS, Manchester, UK. · Orion Corporation Orion Pharma, Espoo, Finland. · Endo Pharmaceuticals, Malvern, USA. · Pubmed 24974051
  • Department of Cancer Medicine, Gustave Roussy, Villejuif, France. · Institut Jean-Godinot, Reims, France. · Pubmed 25311767
  • Department of Medical Oncology, Georges Pompidou European Hospital, Paris, France. · Department of Medicine, Centre Léon Bérard, Lyon, France. · Department of Internal Medicine, Istanbul University Hospitals, Istanbul, Turkey. · Stat Process, Port-Mort, France. · Department of Medicine, Institut de Cancérologie de la Loire, Saint-Etienne, France. · Department of Medical Oncology, Val de Grace Hospital, Paris, France. · Department of Medicine, Institut Paoli Calmettes, Marseille, France. · Department of Medicine, Institut Curie, Paris, France. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Medical Oncology, Pitié-Salpêtrière Hospital, Paris, France. · Department of Medical Oncology, Georges Pompidou European Hospital, Paris, France. Electronic address: · Pubmed 24725337
2011
  • Institut Gustave-Roussy, département de médecine, Villejuif, France. · Pubmed 22172776
  • Institut Gustave Roussy, Department of Cancer Medicine, University of Paris Sud, Unité INSERM U981, Paris, France. · Pubmed 21680543
2010
  • Département de médecine, Institut Gustave- Roussy, Villejuif, France. · Pubmed 20222324
2015
  • a Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, 114 rue Edouard Vaillant, 94800 Villejuif, France. · Pubmed 26313416
2013
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris-Sud, INSERM 981, Villejuif, France. · Pubmed 23576708
2012
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Pubmed 22267211
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif 94800, France. · Pubmed 22987974
2010
  • Department of Medicine, Institut Gustave Roussy, Villejuif, France. · Pubmed 20483588
  • Department of Medicine, Institut Gustave Roussy, University of Paris XI, Villejuif, France. · Pubmed 20181574
  • Institut Gustave-Roussy, Département de Médecine, 39 Rue Camille-Desmoulins, 94800 Villejuif, France. · Pubmed 20022854
  • Department of Radiation, Institut Gustave-Roussy, Villejuif, France. · Pubmed 19825885
2009
  • Institut Gustave-Roussy, 39 bis, rue Camille-Desmoulins, 94800 Villejuif, France. · Pubmed 19357018
  • Department of Medicine, Institut Gustave Roussy, Villejuif, France. · Pubmed 19364971
2008
  • Department of Medicine, Institut Gustave Roussy, Villejuif, France. · Pubmed 18356135
Probable:    Universite Paris 11 Sud      
2018
  • Carolina Urologic Research Center, Myrtle Beach, SC, USA. Electronic address: · Tampere University Hospital, Department of Urology, Tampere, Finland. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Comprehensive Cancer Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland. · Orion Corporation, Orion Pharma, Espoo, Finland. · Pubmed 28753851
2017
  • University of Paris Sud, Gustave-Roussy Cancer Campus, Drug Development Department and Department of Medical Oncology, 114, rue Édouard-Vaillant, 94805 Villejuif cedex, France. · University of Paris Sud, Gustave-Roussy Cancer Campus, Drug Development Department and Department of Medical Oncology, 114, rue Édouard-Vaillant, 94805 Villejuif cedex, France. Electronic address: · Pubmed 28237355
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Comprehensive Cancer Center, Helsinki University Hospital, University of Helsinki, Helsinki, Finland. · Kuopio University Hospital, Kuopio, Finland. · Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK. · Tampere University Hospital, Tampere, Finland. · Orion Corporation, Orion Pharma, Espoo, Finland. · Pubmed 28753849
  • Drug Development Department, Gustave Roussy, University of Paris Sud, Villejuif, France; Department of Cancer Medicine, Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · BC Cancer Agency, Vancouver, Canada. · University Hospital 12 de Octubre, CIBER-ONC, Madrid, Spain. · Institute of Cancer Research, London, UK. · Institut Paoli-Calmettes, Marseille, France. · St. Augustinus Hospital, Antwerp, Belgium. · Institut Roi Albert II, Service d'Oncologie Médicale, Cliniques universitaires Saint-Luc and Institut de Recherche Clinique et Expérimentale, Université catholique de Louvain, Brussels, Belgium. · Cedars-Sinai Medical Center, Los Angeles, CA, USA. · Medical Oncology Department, Hospital Clínic, IDIBAPS, Barcelona, Spain. · Novartis Pharma S.A.S, Rueil-Malmaison, France. · Novartis Pharma AG, Basel, Switzerland. · Novartis Healthcare Pvt. Ltd., Hyderabad, India. · Department of Cancer Medicine, Gustave Roussy, University of Paris Sud, France. · Pubmed 28282611
  • Department of Drug Development, Gustave Roussy Cancer Campus, University of Paris Sud, Villejuif, France. · Department of Medical Oncology, Gustave Roussy Cancer Campus, University of Paris Sud, Villejuif, France. · The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, USA. · Comprehensive Cancer Center Yale School of Medicine, New Haven. · Sanofi Genzyme, Cambridge, USA. · Pubmed 28039155
  • Institut Gustave Roussy, University of Paris-Sud, Department of Cancer Medicine, 114 Rue Edouard Vaillant, 94800 Villejuif, France. · Institut Paoli-Calmettes, Department of Medical Oncology, 13009 Marseille, France. · Pubmed 28428880
2016
  • Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. · Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. Electronic address: · Pubmed 27151554
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Comprehensive Cancer Center, Helsinki University Central Hospital and University of Helsinki, Helsinki, Finland. · Stradins Clinical University Hospital, Riga, Latvia. · Riga East University Hospital, Riga, Latvia. · Tampere University Hospital and School of Medicine, University of Tampere, Tampere, Finland. · Orion Corporation, Orion Pharma, Espoo, Finland. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Pubmed 26463318
  • Department of Medical Oncology, Institut Bergonié, Bordeaux. · Department of Medical Oncology, Clinique Francheville, Périgueux. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif. · Department of Radiotherapy, Institut Bergonié, Bordeaux, France. · Department of Medical Oncology, Institut Bergonié, Bordeaux · Pubmed 26445811
2015
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Pubmed 25922192
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Nyack Hospital, Nyack, NY, USA. · Cancer Research UK Experimental Cancer Medicine Centres, Leeds and Sheffield, UK. · Department of Radiotherapy, Greater Poland Cancer Center and Department of Electroradiology, Medical University, Poznań, Poland. · Carolina Urologic Research Center, Myrtle Beach, SC, USA. · European Georges Pompidou Hospital, Paris, France. · The Urology Center of Colorado, Denver, CO, USA. · Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA. · Universitario Pedro Ernesto, Rio De Janeiro, Brazil. · Amgen Inc., Thousand Oaks, CA, USA. · Pubmed 25449207
  • Department of Ambulatory Care, Gustave-Roussy Cancer Campus, University of Paris Sud, Villejuif, France. Electronic address: · Department of Biostatistics and Epidemiology, Gustave-Roussy Cancer Campus, University of Paris Sud, Villejuif, France. · Department of Cancer Medicine, Gustave-Roussy Cancer Campus, Villejuif, University of Paris Sud, France. · Department of Ambulatory Care, Gustave-Roussy Cancer Campus, University of Paris Sud, Villejuif, France. · Pubmed 26278649
  • Department of Cancer Medicine, Gustave Roussy Institute, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. Electronic address: · Institut Jean Godinot, Reims, France. · Department of Cancer Medicine, Gustave Roussy Institute, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. · Pubmed 26208462
  • Department of Cancer Medicine, Gustave Roussy Institute, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. · Department of Urology, University Hospital of Pointe-à-Pitre, France. · Department of Urology, Kremlin-Bicêtre Hospital, University of Paris-Sud, Kremlin-Bicêtre, France. · Department of Urology, Saint-Joseph Hospital, Paris, France. · Department of Radiotherapy, Gustave Roussy Institute, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. · Department of Forestry and Management of the Environment and Natural Resources, School of Agricultural Sciences and Forestry, Democritus University, Alexandroupoli, Greece. · Department of Cancer Medicine, Gustave Roussy Institute, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. Electronic address: · Pubmed 25746940
  • Unit of Urology/Division of Oncology; URI; IRCCS Ospedale San Raffaele, Milan, Italy. · Department of Urology, Saint-Louis Hospital, Paris, France. · Department of Urology, Regio Clinic Wedel, Wedel, Germany; Martini-Clinic, Prostate Cancer Center Hamburg-Eppendorf, Germany. · Department of Radiology, Ghent University Hospital, Ghent, Belgium. · Department of Radiology, Radboud University, Nijmegen Medical Centre, Nijmegen, The Netherlands. · Department of Radiation Oncology, Charité Universitätsmedizin Berlin, Berlin, Germany. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Radiation Oncology and Experimental Cancer Research, Ghent University Hospital, Ghent, Belgium. · Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK. · Centre of Urological Surgery, Dialysis and Renal Transplantation, Fundeni Clinical Institute, Bucharest, Romania. · Department of Urology, University Medical Centre Utrecht, Utrecht, The Netherlands. · Department of Experimental and Clinical Medical Sciences, University of Udine, Udine, Italy. · Unit of Urology/Division of Oncology; URI; IRCCS Ospedale San Raffaele, Milan, Italy. Electronic address: · Pubmed 25620154
  • Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia, Canada. · Department of Medical Oncology, Val de Grâce Hospital, Paris, France. · Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, and INSERM U981, Villejuif, France. · Department of Medical Oncology, Institut Curie, Paris, France. · Department of Medical Oncology, CHU de Bordeaux, Bordeaux, France. · Pitié-Salpetrière Hospital, Paris, France. · Institut de Cancérologie de la Loire, Saint-Etienne, France. · Biostatistics and Epidemiology unit, Institut Gustave Roussy, Cancer Campus, Grand Paris, Villejuif, France. · Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, and INSERM U981, Villejuif, France. Electronic address: · Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, and INSERM U981, Villejuif, France. Electronic address: · Pubmed 24837187
2014
  • Department of Cancer Medicine, Institut Gustave Roussy and University of Paris Sud, Villejuif, France. · Department of Cancer Medicine, Institut Gustave Roussy and University of Paris Sud, Villejuif, France; Drug Development Department, SITEP, Institut Gustave Roussy, Villejuif, France. Electronic address: · Pubmed 24735730
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Cancer Center, Helsinki University Central Hospital, Helsinki, Finland. · Velindre Cancer Centre, Cardiff, UK. · Kuopio University Hospital, Kuopio, Finland. · Queen Elizabeth Hospital, Birmingham, UK. · Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, USA. · Churchill Hospital, Oxford, UK. · Tampere University Hospital, Tampere, Finland. · Christie Hospital NHS, Manchester, UK. · Orion Corporation Orion Pharma, Espoo, Finland. · Endo Pharmaceuticals, Malvern, USA. · Pubmed 24974051
  • Department of Medical Oncology, Georges Pompidou European Hospital, Paris, France. · Department of Medicine, Centre Léon Bérard, Lyon, France. · Department of Internal Medicine, Istanbul University Hospitals, Istanbul, Turkey. · Stat Process, Port-Mort, France. · Department of Medicine, Institut de Cancérologie de la Loire, Saint-Etienne, France. · Department of Medical Oncology, Val de Grace Hospital, Paris, France. · Department of Medicine, Institut Paoli Calmettes, Marseille, France. · Department of Medicine, Institut Curie, Paris, France. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Medical Oncology, Pitié-Salpêtrière Hospital, Paris, France. · Department of Medical Oncology, Georges Pompidou European Hospital, Paris, France. Electronic address: · Pubmed 24725337
2011
  • Institut Gustave Roussy, Department of Cancer Medicine, University of Paris Sud, Unité INSERM U981, Paris, France. · Pubmed 21680543
2015
  • a Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, 114 rue Edouard Vaillant, 94800 Villejuif, France. · Pubmed 26313416
2013
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris-Sud, INSERM 981, Villejuif, France. · Pubmed 23576708
2012
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Pubmed 22267211
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif 94800, France. · Pubmed 22987974
2010
  • Department of Medicine, Institut Gustave Roussy, University of Paris XI, Villejuif, France. · Pubmed 20181574
2009
  • Department of Medicine, University of Paris XI, Villejuif, France. · Pubmed 19775638
Probable:    INSERM France      
2016
  • Gustave Roussy, Université Paris-Saclay, Department of Medicine, F-94805, Villejuif, France. · INSERM, U981 "Identification of Molecular Predictors and New Targets for Cancer Treatment", F-94805, Villejuif, France. · Gustave Roussy, Université Paris-Saclay, "Circulating Tumor Cells" Translational Platform, AMMICA CNRS UMS3655 - INSERM US23, F-94805, Villejuif, France. · Hôpital d'Instruction des Armées du Val de Grâce, Department of Oncology, F-75005, Paris, France. · Gustave Roussy, Université Paris-Saclay, Department of Biopathology, F-94805, Villejuif, France. · Gustave Roussy, Université Paris-Saclay, Department of Biostatistics and Epidemiology, F-94805, Villejuif, France. · Gustave Roussy, Université Paris-Saclay, "Histo Cytopathology" Translational Platform, AMMICA CNRS UMS3655 - INSERM US23, F-94805, Villejuif, France. · Pubmed 27391263
2015
  • Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia, Canada. · Department of Medical Oncology, Val de Grâce Hospital, Paris, France. · Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, and INSERM U981, Villejuif, France. · Department of Medical Oncology, Institut Curie, Paris, France. · Department of Medical Oncology, CHU de Bordeaux, Bordeaux, France. · Pitié-Salpetrière Hospital, Paris, France. · Institut de Cancérologie de la Loire, Saint-Etienne, France. · Biostatistics and Epidemiology unit, Institut Gustave Roussy, Cancer Campus, Grand Paris, Villejuif, France. · Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, and INSERM U981, Villejuif, France. Electronic address: · Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, and INSERM U981, Villejuif, France. Electronic address: · Pubmed 24837187
2011
  • Institut Gustave Roussy, Department of Cancer Medicine, University of Paris Sud, Unité INSERM U981, Paris, France. · Pubmed 21680543
2013
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris-Sud, INSERM 981, Villejuif, France. · Pubmed 23576708
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 53 total) written by Christophe Massard about Prostatic Neoplasms:

  • Prognostic Biomarkers Used for Localised Prostate Cancer Management: A Systematic Review. 2018
  • Safety and Antitumour Activity of ODM-201 (BAY-1841788) in Chemotherapy-naïve and CYP17 Inhibitor-naïve Patients: Follow-up from the ARADES and ARAFOR Trials. 2018
  • [Immunotherapy for the treatment of patients with genitourinary cancers: Review and perspectives]. 2017
  • Safety and Antitumour Activity of ODM-201 (BAY-1841788) in Castration-resistant, CYP17 Inhibitor-naïve Prostate Cancer: Results from Extended Follow-up of the ARADES Trial. 2017
  • Phase Ib dose-finding study of abiraterone acetate plus buparlisib (BKM120) or dactolisib (BEZ235) in patients with castration-resistant prostate cancer. 2017
  • Phase I/II trial of cabazitaxel plus abiraterone in patients with metastatic castration-resistant prostate cancer (mCRPC) progressing after docetaxel and abiraterone. 2017
  • Long-term complete remission with Ipilimumab in metastatic castrate-resistant prostate cancer: case report of two patients. 2017
  • [Management of a progressing prostate cancer: results of a national study]. 2017
  • First-line management of metastatic castrate-resistant prostate cancer patients: Audit of real-life practices. 2017
  • [Localized prostate cancer: Changes are still expected]. 2016
Show List of Full Article Records
Google Searches

Learn more about Christophe Massard using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Institut Gustave Roussy
Universite Paris 11 Sud
INSERM France
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Institut Gustave Roussy
2018
  • Institut Médical d'Analyse Génomique, Clinique BeauSoleil, Montpellier, France. Electronic address: · Service de Pathologie, CHU Henri Mondor, Créteil, France. · UMR-S INSERM 1039, Institut de Biologie et de Pathologie, CHU Grenoble, Grenoble, France. · IR4M-UMR8081, Université Paris-Sud, Paris, France. · Département Oncologie Médicale, Institut Curie, Paris, France. · Hôpital Saint-Louis, Paris, France. · CHU Henri Mondor, Créteil, France. · Médecine Nucléaire, CHU Bordeaux, Bordeaux, France. · Institut Gustave Roussy, Villejuif, France. · Département d'Imagerie Médicale, CHU Lapeyronie, Montpellier, France. · CHU Montpellier, Montpellier, France. · Service de Biologie Cellulaire, Hôpital Saint-Louis, AP-HP, Paris, France. · Department of Urinary and Vascular Radiology, Hospices Civils de Lyon, Hôpital Edouard Herriot-Université Lyon 1, Lyon, France. · Intergroupe Coopérateur Francophone de Recherche en Onco-urologie, Paris, France. · Institut Mutualiste Montsouris, Paris-Université Paris Descartes, Paris, France. · CHU Grenoble, France. · Service d'Urologie, Clinique BeauSoleil, Montpellier, France. · Pubmed 28753865
  • Carolina Urologic Research Center, Myrtle Beach, SC, USA. Electronic address: · Tampere University Hospital, Department of Urology, Tampere, Finland. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Comprehensive Cancer Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland. · Orion Corporation, Orion Pharma, Espoo, Finland. · Pubmed 28753851
2017
  • University of Paris Sud, Gustave-Roussy Cancer Campus, Drug Development Department and Department of Medical Oncology, 114, rue Édouard-Vaillant, 94805 Villejuif cedex, France. · University of Paris Sud, Gustave-Roussy Cancer Campus, Drug Development Department and Department of Medical Oncology, 114, rue Édouard-Vaillant, 94805 Villejuif cedex, France. Electronic address: · Pubmed 28237355
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Comprehensive Cancer Center, Helsinki University Hospital, University of Helsinki, Helsinki, Finland. · Kuopio University Hospital, Kuopio, Finland. · Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK. · Tampere University Hospital, Tampere, Finland. · Orion Corporation, Orion Pharma, Espoo, Finland. · Pubmed 28753849
  • Drug Development Department, Gustave Roussy, University of Paris Sud, Villejuif, France; Department of Cancer Medicine, Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · BC Cancer Agency, Vancouver, Canada. · University Hospital 12 de Octubre, CIBER-ONC, Madrid, Spain. · Institute of Cancer Research, London, UK. · Institut Paoli-Calmettes, Marseille, France. · St. Augustinus Hospital, Antwerp, Belgium. · Institut Roi Albert II, Service d'Oncologie Médicale, Cliniques universitaires Saint-Luc and Institut de Recherche Clinique et Expérimentale, Université catholique de Louvain, Brussels, Belgium. · Cedars-Sinai Medical Center, Los Angeles, CA, USA. · Medical Oncology Department, Hospital Clínic, IDIBAPS, Barcelona, Spain. · Novartis Pharma S.A.S, Rueil-Malmaison, France. · Novartis Pharma AG, Basel, Switzerland. · Novartis Healthcare Pvt. Ltd., Hyderabad, India. · Department of Cancer Medicine, Gustave Roussy, University of Paris Sud, France. · Pubmed 28282611
  • Department of Drug Development, Gustave Roussy Cancer Campus, University of Paris Sud, Villejuif, France. · Department of Medical Oncology, Gustave Roussy Cancer Campus, University of Paris Sud, Villejuif, France. · The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, USA. · Comprehensive Cancer Center Yale School of Medicine, New Haven. · Sanofi Genzyme, Cambridge, USA. · Pubmed 28039155
  • Institut Gustave Roussy, University of Paris-Sud, Department of Cancer Medicine, 114 Rue Edouard Vaillant, 94800 Villejuif, France. · Institut Paoli-Calmettes, Department of Medical Oncology, 13009 Marseille, France. · Pubmed 28428880
  • Institut Montsouris, université Paris Descartes, 42, boulevard Jourdan, 75014 Paris, France. Electronic address: · Hôpital Pitié Salpêtrière, Assistance publique-Hôpitaux de Paris, faculté de médecine Pierre-et-Marie-Curie, université Paris 6, 47-83, boulevard de l'Hôpital, 75013 Paris, France. · Hôpital St-Louis, université Paris Diderot, 1, avenue Claude-Vellefaux, 75010 Paris, France. · Institut Gustave-Roussy, 114, rue Édouard-Vaillant, 94800 Villejuif, France. · Institut Bergonié, 229, cours de l'Argonne, 33000 Bordeaux, France. · Pubmed 28392429
  • CHRU de Lille, medical oncology department, rue Michel-Polonovski, 59037 Lille cedex, France; Institut de biologie de Lille, CNRS-UMR8161, 1, rue du Professeur-Calmette, 59021 Lille cedex, France. Electronic address: · Centre Oscar-Lambret, department of radiotherapy, 3, rue F.-Combemale, 59020 Lille, France. · Gustave-Roussy hospital, department of therapeutic innovation and early trials, 114, rue Edouard-Vaillant, 94800 Villejuif, France. · Clinique Sainte-Marguerite, medical oncology department, oncovar, avenue Alexis-Godillot, 83400 Hyères, France. · AP-HP, Saint-Louis hospital, medical oncology, 75010 Paris, France. · Centre Oscar-Lambret, medical oncology department, 3, rue F.-Combemale, 59020 Lille, France; SIRIC ONCOLille Consortium, Clinical Research and Methodology Platform, 59000 Lille, France. · Pubmed 28390646
2016
  • Hôpitaux de Chartres Oncologie-Hématologie, 6, rue Claude-Bernard, 28630 Chartes Le Coudray, France. Electronic address: · CHU de Clermont-Ferrand, service de thérapie cellulaire et d'hématologie clinique adulte, 1, place Lucie-Aubrac, 63003 Clermont-Ferrand cedex 1, France. · Institut Gustave-Roussy, département de médecine, 114, rue Édouard-Vaillant, 94800 Villejuif, France. · Centre Antoine-Lacassagne, département de radiothérapie, 33, avenue Valombrose, 06189 Nice, France. · Pubmed 27770995
  • Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. · Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. Electronic address: · Pubmed 27151554
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Comprehensive Cancer Center, Helsinki University Central Hospital and University of Helsinki, Helsinki, Finland. · Stradins Clinical University Hospital, Riga, Latvia. · Riga East University Hospital, Riga, Latvia. · Tampere University Hospital and School of Medicine, University of Tampere, Tampere, Finland. · Orion Corporation, Orion Pharma, Espoo, Finland. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Pubmed 26463318
  • Gustave Roussy, Université Paris-Saclay, Department of Medicine, F-94805, Villejuif, France. · INSERM, U981 "Identification of Molecular Predictors and New Targets for Cancer Treatment", F-94805, Villejuif, France. · Gustave Roussy, Université Paris-Saclay, "Circulating Tumor Cells" Translational Platform, AMMICA CNRS UMS3655 - INSERM US23, F-94805, Villejuif, France. · Hôpital d'Instruction des Armées du Val de Grâce, Department of Oncology, F-75005, Paris, France. · Gustave Roussy, Université Paris-Saclay, Department of Biopathology, F-94805, Villejuif, France. · Gustave Roussy, Université Paris-Saclay, Department of Biostatistics and Epidemiology, F-94805, Villejuif, France. · Gustave Roussy, Université Paris-Saclay, "Histo Cytopathology" Translational Platform, AMMICA CNRS UMS3655 - INSERM US23, F-94805, Villejuif, France. · Pubmed 27391263
  • INSERM U981, University of Paris-Sud XI, Translational Research Laboratory, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Medical Oncology, Bergonie Cancer Institute, Bordeaux, France. · INSERM U981, University of Paris-Sud XI, Translational Research Laboratory, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. · INSERM U981, University of Paris-Sud XI, Translational Research Laboratory, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Biopathology, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. · INSERM U981, University of Paris-Sud XI, Translational Research Laboratory, Gustave Roussy Cancer Campus, Villejuif, France. · Pubmed 26923772
  • Department of Medical Oncology, Institut Bergonié, Bordeaux. · Department of Medical Oncology, Clinique Francheville, Périgueux. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif. · Department of Radiotherapy, Institut Bergonié, Bordeaux, France. · Department of Medical Oncology, Institut Bergonié, Bordeaux · Pubmed 26445811
2015
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Pubmed 25922192
  • Institut Curie, département d'oncologie médicale, 26, rue d'Ulm, 75005 Paris, France. Electronic address: · Institut Gustave-Roussy, département d'oncologie médicale, 94076 Villejuif, France. · Pubmed 26028494
  • Gustave-Roussy, département innovation thérapeutique et essais précoces, 114, rue Édouard-Vaillant, 94805 Villejuif, France. · Gustave-Roussy, département innovation thérapeutique et essais précoces, 114, rue Édouard-Vaillant, 94805 Villejuif, France. Electronic address: · Pubmed 26022286
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Nyack Hospital, Nyack, NY, USA. · Cancer Research UK Experimental Cancer Medicine Centres, Leeds and Sheffield, UK. · Department of Radiotherapy, Greater Poland Cancer Center and Department of Electroradiology, Medical University, Poznań, Poland. · Carolina Urologic Research Center, Myrtle Beach, SC, USA. · European Georges Pompidou Hospital, Paris, France. · The Urology Center of Colorado, Denver, CO, USA. · Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA. · Universitario Pedro Ernesto, Rio De Janeiro, Brazil. · Amgen Inc., Thousand Oaks, CA, USA. · Pubmed 25449207
  • Department of Ambulatory Care, Gustave-Roussy Cancer Campus, University of Paris Sud, Villejuif, France. Electronic address: · Department of Biostatistics and Epidemiology, Gustave-Roussy Cancer Campus, University of Paris Sud, Villejuif, France. · Department of Cancer Medicine, Gustave-Roussy Cancer Campus, Villejuif, University of Paris Sud, France. · Department of Ambulatory Care, Gustave-Roussy Cancer Campus, University of Paris Sud, Villejuif, France. · Pubmed 26278649
  • Department of Cancer Medicine, Gustave Roussy Institute, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. Electronic address: · Institut Jean Godinot, Reims, France. · Department of Cancer Medicine, Gustave Roussy Institute, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. · Pubmed 26208462
  • Department of Cancer Medicine, Gustave Roussy Institute, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. · Department of Urology, University Hospital of Pointe-à-Pitre, France. · Department of Urology, Kremlin-Bicêtre Hospital, University of Paris-Sud, Kremlin-Bicêtre, France. · Department of Urology, Saint-Joseph Hospital, Paris, France. · Department of Radiotherapy, Gustave Roussy Institute, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. · Department of Forestry and Management of the Environment and Natural Resources, School of Agricultural Sciences and Forestry, Democritus University, Alexandroupoli, Greece. · Department of Cancer Medicine, Gustave Roussy Institute, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. Electronic address: · Pubmed 25746940
  • Unit of Urology/Division of Oncology; URI; IRCCS Ospedale San Raffaele, Milan, Italy. · Department of Urology, Saint-Louis Hospital, Paris, France. · Department of Urology, Regio Clinic Wedel, Wedel, Germany; Martini-Clinic, Prostate Cancer Center Hamburg-Eppendorf, Germany. · Department of Radiology, Ghent University Hospital, Ghent, Belgium. · Department of Radiology, Radboud University, Nijmegen Medical Centre, Nijmegen, The Netherlands. · Department of Radiation Oncology, Charité Universitätsmedizin Berlin, Berlin, Germany. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Radiation Oncology and Experimental Cancer Research, Ghent University Hospital, Ghent, Belgium. · Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK. · Centre of Urological Surgery, Dialysis and Renal Transplantation, Fundeni Clinical Institute, Bucharest, Romania. · Department of Urology, University Medical Centre Utrecht, Utrecht, The Netherlands. · Department of Experimental and Clinical Medical Sciences, University of Udine, Udine, Italy. · Unit of Urology/Division of Oncology; URI; IRCCS Ospedale San Raffaele, Milan, Italy. Electronic address: · Pubmed 25620154
  • Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia, Canada. · Department of Medical Oncology, Val de Grâce Hospital, Paris, France. · Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, and INSERM U981, Villejuif, France. · Department of Medical Oncology, Institut Curie, Paris, France. · Department of Medical Oncology, CHU de Bordeaux, Bordeaux, France. · Pitié-Salpetrière Hospital, Paris, France. · Institut de Cancérologie de la Loire, Saint-Etienne, France. · Biostatistics and Epidemiology unit, Institut Gustave Roussy, Cancer Campus, Grand Paris, Villejuif, France. · Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, and INSERM U981, Villejuif, France. Electronic address: · Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, and INSERM U981, Villejuif, France. Electronic address: · Pubmed 24837187
2014
  • Department of Cancer Medicine, Institut Gustave Roussy and University of Paris Sud, Villejuif, France. · Department of Cancer Medicine, Institut Gustave Roussy and University of Paris Sud, Villejuif, France; Drug Development Department, SITEP, Institut Gustave Roussy, Villejuif, France. Electronic address: · Pubmed 24735730
  • Institut Gustave-Roussy, DITEP, Département d'innovations thérapeutiques et essais précoces, 114, rue Édouard-Vaillant, 94805 Villejuif cedex, France. · Institut Gustave-Roussy, Département de médecine oncologique, 114, rue Édouard-Vaillant, 94805 Villejuif cedex, France. · Service d'oncologie et hématologie, 4, rue Louis-Pasteur, 28630 Chartres Le Coudray, France. · Pubmed 24793632
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Cancer Center, Helsinki University Central Hospital, Helsinki, Finland. · Velindre Cancer Centre, Cardiff, UK. · Kuopio University Hospital, Kuopio, Finland. · Queen Elizabeth Hospital, Birmingham, UK. · Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, USA. · Churchill Hospital, Oxford, UK. · Tampere University Hospital, Tampere, Finland. · Christie Hospital NHS, Manchester, UK. · Orion Corporation Orion Pharma, Espoo, Finland. · Endo Pharmaceuticals, Malvern, USA. · Pubmed 24974051
  • Department of Cancer Medicine, Gustave Roussy, Villejuif, France. · Institut Jean-Godinot, Reims, France. · Pubmed 25311767
  • Department of Medical Oncology, Georges Pompidou European Hospital, Paris, France. · Department of Medicine, Centre Léon Bérard, Lyon, France. · Department of Internal Medicine, Istanbul University Hospitals, Istanbul, Turkey. · Stat Process, Port-Mort, France. · Department of Medicine, Institut de Cancérologie de la Loire, Saint-Etienne, France. · Department of Medical Oncology, Val de Grace Hospital, Paris, France. · Department of Medicine, Institut Paoli Calmettes, Marseille, France. · Department of Medicine, Institut Curie, Paris, France. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Medical Oncology, Pitié-Salpêtrière Hospital, Paris, France. · Department of Medical Oncology, Georges Pompidou European Hospital, Paris, France. Electronic address: · Pubmed 24725337
2011
  • Institut Gustave-Roussy, département de médecine, Villejuif, France. · Pubmed 22172776
  • Institut Gustave Roussy, Department of Cancer Medicine, University of Paris Sud, Unité INSERM U981, Paris, France. · Pubmed 21680543
2010
  • Département de médecine, Institut Gustave- Roussy, Villejuif, France. · Pubmed 20222324
2015
  • a Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, 114 rue Edouard Vaillant, 94800 Villejuif, France. · Pubmed 26313416
2013
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris-Sud, INSERM 981, Villejuif, France. · Pubmed 23576708
2012
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Pubmed 22267211
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif 94800, France. · Pubmed 22987974
2010
  • Department of Medicine, Institut Gustave Roussy, Villejuif, France. · Pubmed 20483588
  • Department of Medicine, Institut Gustave Roussy, University of Paris XI, Villejuif, France. · Pubmed 20181574
  • Institut Gustave-Roussy, Département de Médecine, 39 Rue Camille-Desmoulins, 94800 Villejuif, France. · Pubmed 20022854
  • Department of Radiation, Institut Gustave-Roussy, Villejuif, France. · Pubmed 19825885
2009
  • Institut Gustave-Roussy, 39 bis, rue Camille-Desmoulins, 94800 Villejuif, France. · Pubmed 19357018
  • Department of Medicine, Institut Gustave Roussy, Villejuif, France. · Pubmed 19364971
2008
  • Department of Medicine, Institut Gustave Roussy, Villejuif, France. · Pubmed 18356135
Universite Paris 11 Sud
2018
  • Carolina Urologic Research Center, Myrtle Beach, SC, USA. Electronic address: · Tampere University Hospital, Department of Urology, Tampere, Finland. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Comprehensive Cancer Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland. · Orion Corporation, Orion Pharma, Espoo, Finland. · Pubmed 28753851
2017
  • University of Paris Sud, Gustave-Roussy Cancer Campus, Drug Development Department and Department of Medical Oncology, 114, rue Édouard-Vaillant, 94805 Villejuif cedex, France. · University of Paris Sud, Gustave-Roussy Cancer Campus, Drug Development Department and Department of Medical Oncology, 114, rue Édouard-Vaillant, 94805 Villejuif cedex, France. Electronic address: · Pubmed 28237355
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Comprehensive Cancer Center, Helsinki University Hospital, University of Helsinki, Helsinki, Finland. · Kuopio University Hospital, Kuopio, Finland. · Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK. · Tampere University Hospital, Tampere, Finland. · Orion Corporation, Orion Pharma, Espoo, Finland. · Pubmed 28753849
  • Drug Development Department, Gustave Roussy, University of Paris Sud, Villejuif, France; Department of Cancer Medicine, Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · BC Cancer Agency, Vancouver, Canada. · University Hospital 12 de Octubre, CIBER-ONC, Madrid, Spain. · Institute of Cancer Research, London, UK. · Institut Paoli-Calmettes, Marseille, France. · St. Augustinus Hospital, Antwerp, Belgium. · Institut Roi Albert II, Service d'Oncologie Médicale, Cliniques universitaires Saint-Luc and Institut de Recherche Clinique et Expérimentale, Université catholique de Louvain, Brussels, Belgium. · Cedars-Sinai Medical Center, Los Angeles, CA, USA. · Medical Oncology Department, Hospital Clínic, IDIBAPS, Barcelona, Spain. · Novartis Pharma S.A.S, Rueil-Malmaison, France. · Novartis Pharma AG, Basel, Switzerland. · Novartis Healthcare Pvt. Ltd., Hyderabad, India. · Department of Cancer Medicine, Gustave Roussy, University of Paris Sud, France. · Pubmed 28282611
  • Department of Drug Development, Gustave Roussy Cancer Campus, University of Paris Sud, Villejuif, France. · Department of Medical Oncology, Gustave Roussy Cancer Campus, University of Paris Sud, Villejuif, France. · The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, USA. · Comprehensive Cancer Center Yale School of Medicine, New Haven. · Sanofi Genzyme, Cambridge, USA. · Pubmed 28039155
  • Institut Gustave Roussy, University of Paris-Sud, Department of Cancer Medicine, 114 Rue Edouard Vaillant, 94800 Villejuif, France. · Institut Paoli-Calmettes, Department of Medical Oncology, 13009 Marseille, France. · Pubmed 28428880
2016
  • Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. · Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. Electronic address: · Pubmed 27151554
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Comprehensive Cancer Center, Helsinki University Central Hospital and University of Helsinki, Helsinki, Finland. · Stradins Clinical University Hospital, Riga, Latvia. · Riga East University Hospital, Riga, Latvia. · Tampere University Hospital and School of Medicine, University of Tampere, Tampere, Finland. · Orion Corporation, Orion Pharma, Espoo, Finland. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Pubmed 26463318
  • Department of Medical Oncology, Institut Bergonié, Bordeaux. · Department of Medical Oncology, Clinique Francheville, Périgueux. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif. · Department of Radiotherapy, Institut Bergonié, Bordeaux, France. · Department of Medical Oncology, Institut Bergonié, Bordeaux · Pubmed 26445811
2015
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Pubmed 25922192
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Nyack Hospital, Nyack, NY, USA. · Cancer Research UK Experimental Cancer Medicine Centres, Leeds and Sheffield, UK. · Department of Radiotherapy, Greater Poland Cancer Center and Department of Electroradiology, Medical University, Poznań, Poland. · Carolina Urologic Research Center, Myrtle Beach, SC, USA. · European Georges Pompidou Hospital, Paris, France. · The Urology Center of Colorado, Denver, CO, USA. · Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA. · Universitario Pedro Ernesto, Rio De Janeiro, Brazil. · Amgen Inc., Thousand Oaks, CA, USA. · Pubmed 25449207
  • Department of Ambulatory Care, Gustave-Roussy Cancer Campus, University of Paris Sud, Villejuif, France. Electronic address: · Department of Biostatistics and Epidemiology, Gustave-Roussy Cancer Campus, University of Paris Sud, Villejuif, France. · Department of Cancer Medicine, Gustave-Roussy Cancer Campus, Villejuif, University of Paris Sud, France. · Department of Ambulatory Care, Gustave-Roussy Cancer Campus, University of Paris Sud, Villejuif, France. · Pubmed 26278649
  • Department of Cancer Medicine, Gustave Roussy Institute, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. Electronic address: · Institut Jean Godinot, Reims, France. · Department of Cancer Medicine, Gustave Roussy Institute, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. · Pubmed 26208462
  • Department of Cancer Medicine, Gustave Roussy Institute, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. · Department of Urology, University Hospital of Pointe-à-Pitre, France. · Department of Urology, Kremlin-Bicêtre Hospital, University of Paris-Sud, Kremlin-Bicêtre, France. · Department of Urology, Saint-Joseph Hospital, Paris, France. · Department of Radiotherapy, Gustave Roussy Institute, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. · Department of Forestry and Management of the Environment and Natural Resources, School of Agricultural Sciences and Forestry, Democritus University, Alexandroupoli, Greece. · Department of Cancer Medicine, Gustave Roussy Institute, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. Electronic address: · Pubmed 25746940
  • Unit of Urology/Division of Oncology; URI; IRCCS Ospedale San Raffaele, Milan, Italy. · Department of Urology, Saint-Louis Hospital, Paris, France. · Department of Urology, Regio Clinic Wedel, Wedel, Germany; Martini-Clinic, Prostate Cancer Center Hamburg-Eppendorf, Germany. · Department of Radiology, Ghent University Hospital, Ghent, Belgium. · Department of Radiology, Radboud University, Nijmegen Medical Centre, Nijmegen, The Netherlands. · Department of Radiation Oncology, Charité Universitätsmedizin Berlin, Berlin, Germany. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Radiation Oncology and Experimental Cancer Research, Ghent University Hospital, Ghent, Belgium. · Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK. · Centre of Urological Surgery, Dialysis and Renal Transplantation, Fundeni Clinical Institute, Bucharest, Romania. · Department of Urology, University Medical Centre Utrecht, Utrecht, The Netherlands. · Department of Experimental and Clinical Medical Sciences, University of Udine, Udine, Italy. · Unit of Urology/Division of Oncology; URI; IRCCS Ospedale San Raffaele, Milan, Italy. Electronic address: · Pubmed 25620154
  • Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia, Canada. · Department of Medical Oncology, Val de Grâce Hospital, Paris, France. · Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, and INSERM U981, Villejuif, France. · Department of Medical Oncology, Institut Curie, Paris, France. · Department of Medical Oncology, CHU de Bordeaux, Bordeaux, France. · Pitié-Salpetrière Hospital, Paris, France. · Institut de Cancérologie de la Loire, Saint-Etienne, France. · Biostatistics and Epidemiology unit, Institut Gustave Roussy, Cancer Campus, Grand Paris, Villejuif, France. · Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, and INSERM U981, Villejuif, France. Electronic address: · Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, and INSERM U981, Villejuif, France. Electronic address: · Pubmed 24837187
2014
  • Department of Cancer Medicine, Institut Gustave Roussy and University of Paris Sud, Villejuif, France. · Department of Cancer Medicine, Institut Gustave Roussy and University of Paris Sud, Villejuif, France; Drug Development Department, SITEP, Institut Gustave Roussy, Villejuif, France. Electronic address: · Pubmed 24735730
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Cancer Center, Helsinki University Central Hospital, Helsinki, Finland. · Velindre Cancer Centre, Cardiff, UK. · Kuopio University Hospital, Kuopio, Finland. · Queen Elizabeth Hospital, Birmingham, UK. · Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, USA. · Churchill Hospital, Oxford, UK. · Tampere University Hospital, Tampere, Finland. · Christie Hospital NHS, Manchester, UK. · Orion Corporation Orion Pharma, Espoo, Finland. · Endo Pharmaceuticals, Malvern, USA. · Pubmed 24974051
  • Department of Medical Oncology, Georges Pompidou European Hospital, Paris, France. · Department of Medicine, Centre Léon Bérard, Lyon, France. · Department of Internal Medicine, Istanbul University Hospitals, Istanbul, Turkey. · Stat Process, Port-Mort, France. · Department of Medicine, Institut de Cancérologie de la Loire, Saint-Etienne, France. · Department of Medical Oncology, Val de Grace Hospital, Paris, France. · Department of Medicine, Institut Paoli Calmettes, Marseille, France. · Department of Medicine, Institut Curie, Paris, France. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Medical Oncology, Pitié-Salpêtrière Hospital, Paris, France. · Department of Medical Oncology, Georges Pompidou European Hospital, Paris, France. Electronic address: · Pubmed 24725337
2011
  • Institut Gustave Roussy, Department of Cancer Medicine, University of Paris Sud, Unité INSERM U981, Paris, France. · Pubmed 21680543
2015
  • a Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, 114 rue Edouard Vaillant, 94800 Villejuif, France. · Pubmed 26313416
2013
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris-Sud, INSERM 981, Villejuif, France. · Pubmed 23576708
2012
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Pubmed 22267211
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif 94800, France. · Pubmed 22987974
2010
  • Department of Medicine, Institut Gustave Roussy, University of Paris XI, Villejuif, France. · Pubmed 20181574
2009
  • Department of Medicine, University of Paris XI, Villejuif, France. · Pubmed 19775638
INSERM France
2016
  • Gustave Roussy, Université Paris-Saclay, Department of Medicine, F-94805, Villejuif, France. · INSERM, U981 "Identification of Molecular Predictors and New Targets for Cancer Treatment", F-94805, Villejuif, France. · Gustave Roussy, Université Paris-Saclay, "Circulating Tumor Cells" Translational Platform, AMMICA CNRS UMS3655 - INSERM US23, F-94805, Villejuif, France. · Hôpital d'Instruction des Armées du Val de Grâce, Department of Oncology, F-75005, Paris, France. · Gustave Roussy, Université Paris-Saclay, Department of Biopathology, F-94805, Villejuif, France. · Gustave Roussy, Université Paris-Saclay, Department of Biostatistics and Epidemiology, F-94805, Villejuif, France. · Gustave Roussy, Université Paris-Saclay, "Histo Cytopathology" Translational Platform, AMMICA CNRS UMS3655 - INSERM US23, F-94805, Villejuif, France. · Pubmed 27391263
2015
  • Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia, Canada. · Department of Medical Oncology, Val de Grâce Hospital, Paris, France. · Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, and INSERM U981, Villejuif, France. · Department of Medical Oncology, Institut Curie, Paris, France. · Department of Medical Oncology, CHU de Bordeaux, Bordeaux, France. · Pitié-Salpetrière Hospital, Paris, France. · Institut de Cancérologie de la Loire, Saint-Etienne, France. · Biostatistics and Epidemiology unit, Institut Gustave Roussy, Cancer Campus, Grand Paris, Villejuif, France. · Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, and INSERM U981, Villejuif, France. Electronic address: · Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, and INSERM U981, Villejuif, France. Electronic address: · Pubmed 24837187
2011
  • Institut Gustave Roussy, Department of Cancer Medicine, University of Paris Sud, Unité INSERM U981, Paris, France. · Pubmed 21680543
2013
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris-Sud, INSERM 981, Villejuif, France. · Pubmed 23576708
Universite Paris-Saclay
2016
  • Gustave Roussy, Université Paris-Saclay, Department of Medicine, F-94805, Villejuif, France. · INSERM, U981 "Identification of Molecular Predictors and New Targets for Cancer Treatment", F-94805, Villejuif, France. · Gustave Roussy, Université Paris-Saclay, "Circulating Tumor Cells" Translational Platform, AMMICA CNRS UMS3655 - INSERM US23, F-94805, Villejuif, France. · Hôpital d'Instruction des Armées du Val de Grâce, Department of Oncology, F-75005, Paris, France. · Gustave Roussy, Université Paris-Saclay, Department of Biopathology, F-94805, Villejuif, France. · Gustave Roussy, Université Paris-Saclay, Department of Biostatistics and Epidemiology, F-94805, Villejuif, France. · Gustave Roussy, Université Paris-Saclay, "Histo Cytopathology" Translational Platform, AMMICA CNRS UMS3655 - INSERM US23, F-94805, Villejuif, France. · Pubmed 27391263
4 Other Locations Show
Yearly article counts 0276105135761
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.